Literature DB >> 6230977

The acquired immunodeficiency syndrome in patients with hemophilia.

B L Evatt, R B Ramsey, D N Lawrence, L D Zyla, J W Curran.   

Abstract

Since mid-1981 the Centers for Disease Control (CDC) has received reports of more than 1900 cases of the acquired immunodeficiency syndrome. These cases had either Kaposi's sarcoma confirmed by biopsy or a life-threatening opportunistic infection confirmed by biopsy or culture. In January 1982 a hemophiliac with Pneumocystis carinii pneumonia was reported to the CDC, and by July 1982 two other hemophiliacs had developed P. carinii pneumonia. During the next 12 months a total of 22 confirmed cases of the acquired immunodeficiency syndrome occurred in hemophiliacs, 17 in the United States and 5 outside the United States. We report the nature of the epidemic of the acquired immunodeficiency syndrome in hemophiliacs and summarize pertinent clinical aspects.

Entities:  

Mesh:

Year:  1984        PMID: 6230977     DOI: 10.7326/0003-4819-100-4-499

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Factor VIII concentrate for hemophilia: comparison of two heat-treated products.

Authors:  I R Walker; M K Pai; B A Blair; M A Johnston; N J Birkett; F A Ofosu; D H Naylor
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

2.  Seroconversion of human T cell lymphotrophic virus III (HTLV-III) in patients with haemophilia: a longitudinal study.

Authors:  S E Ball; J M Hows; A M Worsley; L Luzzatto; A C Chu; R Meacham; J Morris; R Cheingsong-Popov; R A Weiss; R Tedder
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

3.  Neuropathology of HIV infection in haemophiliacs: comparative necropsy study.

Authors:  M M Esiri; F Scaravilli; P R Millard; J N Harcourt-Webster
Journal:  BMJ       Date:  1989-11-25

Review 4.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

5.  Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.

Authors:  G D Morse; A Portmore; J Olson; C Taylor; C Plank; R C Reichman
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

6.  Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV).

Authors:  R A Sharp; S M Morley; J S Beck; G E Urquhart
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

7.  AIDS and haemophilia: morbidity and morality in a well defined population.

Authors:  P Jones; P J Hamilton; G Bird; M Fearns; A Oxley; R Tedder; R Cheingsong-Popov; A Codd
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

8.  Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.

Authors:  G D Morse; A C Portmore; V Marder; C Plank; J Olson; C Taylor; W Bonnez; R C Reichman
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 9.  Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.

Authors:  P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.